Cargando…
c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers
Spine pathology has been implicated in the early onset of Alzheimer’s disease (AD), where Aβ-Oligomers (AβOs) cause synaptic dysfunction and loss. Previously, we described that pharmacological inhibition of c-Abl prevents AβOs-induced synaptic alterations. Hence, this kinase seems to be a key elemen...
Autores principales: | Gutierrez, Daniela A., Vargas, Lina M., Chandia-Cristi, América, de la Fuente, Catalina, Leal, Nancy, Alvarez, Alejandra R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902026/ https://www.ncbi.nlm.nih.gov/pubmed/31849613 http://dx.doi.org/10.3389/fncel.2019.00526 |
Ejemplares similares
-
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases
por: Gutiérrez, Daniela A., et al.
Publicado: (2022) -
c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth
por: Chandía-Cristi, América, et al.
Publicado: (2023) -
EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
por: M. Vargas, Lina, et al.
Publicado: (2014) -
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
por: Gutierrez, Berenice A., et al.
Publicado: (2022) -
Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer’s Disease Amyloid Beta Oligomers
por: Zolochevska, Olga, et al.
Publicado: (2020)